Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
AstraZeneca
McKesson
Moodys
Medtronic

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Torrent Pharms Llc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for TORRENT PHARMS LLC, and what generic and branded alternatives to TORRENT PHARMS LLC drugs are available?

TORRENT PHARMS LLC has three approved drugs.

There is one tentative approval on TORRENT PHARMS LLC drugs.

Summary for Torrent Pharms Llc
US Patents:0
Tradenames:4
Ingredients:3
NDAs:3

Drugs and US Patents for Torrent Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms Llc OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 091415-002 Oct 25, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms Llc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090899-003 Jun 1, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms Llc CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 079191-001 Apr 15, 2010 OTC No No   Start Trial   Start Trial
Torrent Pharms Llc OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 091415-003 Oct 25, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms Llc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 090899-002 Jun 1, 2011 AB RX No No   Start Trial   Start Trial
Torrent Pharms Llc CETIRIZINE HYDROCHLORIDE ALLERGY cetirizine hydrochloride TABLET;ORAL 079191-004 Apr 15, 2010 OTC No No   Start Trial   Start Trial
Torrent Pharms Llc CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride TABLET;ORAL 079191-002 Apr 15, 2010 OTC No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
Mallinckrodt
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.